跳至主要内容
临床试验/NCT07054697
NCT07054697已完成4 期

A Single-blind Randomized Placebo Controlled Pilot Study With Individualized Homeopathic Treatment in the Children With Autism Spectrum Disorder

Aditi Chadha1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2017年1月1日最近更新:
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
54
试验地点
1
主要终点
Childhood Autism Rating Scale (CARS)

研究概览

简要总结

This study looked at whether homeopathic treatment could help children with Autism Spectrum Disorder (ASD) when used alongside regular therapies like speech and occupational therapy. Over seven years, children between the ages of 2 and 12 were divided into two groups (through computer generated list). One group received individualized homeopathic medicines, and the other received a look-alike placebo (with no active ingredients). Meanwhile, both the groups continued with their regular therapies.

Researchers used various tools and parent questionnaires to track the children's progress in areas like communication, behavior, social skills, daily functioning, toilet training and sensory skills. They found that the children who received homeopathic treatment showed more improvement in these areas compared to those who just received only speech / occupational therapies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
3 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • A confirmed diagnosis of Autism Spectrum Disorder (ABC score ≥ 67)
  • Age range of 2 to 12 years

排除标准

  • Children with other significant comorbid psychiatric conditions that could confound the results. [eg. a brain injury; fragile X syndrome or other syndromes resulting from known genetic defects or inherited metabolic diseases; other diagnosed conditions involving impairments in social and communication abilities, such as intellectual disability without ASD, schizophrenia, language disorders and social communication disorder]
  • Children with irregular follow ups.
  • Children with poor medical compliance.

研究组 & 干预措施

HOMOEOPATHIC GROUP

Experimental

干预措施: Homoeopathic medicines (Drug)

HOMOEOPATHIC GROUP

Experimental

干预措施: THERAPY (Behavioral)

CONTROL GROUP

Placebo Comparator

SACCHARUM LACTIS

干预措施: Placebo (Drug)

CONTROL GROUP

Placebo Comparator

SACCHARUM LACTIS

干预措施: THERAPY (Behavioral)

结局指标

主要结局

Childhood Autism Rating Scale (CARS)

时间窗: BASELINE, YEARLY (0-7 YEARS)

To measure various behavioral dimensions and adaptive functioning

Autism Treatment Evaluation Checklist (ATEC)

时间窗: BASELINE, YEARLY (0 - 7 YEARS)

To assess the efficacy of the treatment among both the arms.

次要结局

  • Social Responsiveness Scale (SRS)(BASELINE, YEARLY (0 - 7 YEARS))
  • Neurodevelopmental Parent Report for Outcome Monitoring (ND PROM)(BASELINE, YEARLY (0 - 7 YEARS))

研究者

发起方
Aditi Chadha
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Aditi Chadha

DOCTOR

Tatva Homoeopathic Clinic and Research Centre

研究点 (1)

Loading locations...

相似试验